Список цитируемой и рекомендуемой литературы
Золото
Empire Rheumatism Council. — Ann. rheumat. Dis., 1960, 19, 95.
Gerber R. C, Paulus H. E. Gold therapy. — Clin, rheumat. Dis., 1975, 1, 307.
Lorber A. Monitorin gold plasma levels in rheumatoid arthritis. — Clin. Pharmacokinetics, 1977, 2, 127.
Lorber A., Atkins C. J., Chang С. С et al. Monitoring serum gold values to improve chrysotherapy in rheumatoid arthritis. — Ann. rheumat. Dis., 1973, 32, 133.
Research Sub-Committee of the Empire Rheumatism Council. Gold therapy in rheumatoid arthritis. Final report of a multicentre controlled trial. — Ann, rheumat. Dis., 1961, 20, 315.
Rothermich N. 0., Philips V. K., Bergen W., Thomas M. H. Chrysotherapy. A prospective study. — Arthr. and Rheum., 1976, 19, 1321.
Sigler J. W., Bluhm G. В., Duncan H. et al. Gold salts in the treatment of rheumatoid arthritis. — Ann. intern. Med., 1974, 80, 21.
Vorenkamp E. O., de Blecourt J. J. VII European Rheumatism Conference,Brighton, England, 1971.
Пеницилламин
Day А. Т., Golding J. R., Lee P. N. et al. Penicillamine in rheumatoid disease: A long term study. — Brit. med. J., 1974, 1, 180.
Huskinsson E. C. Penicillamine and the rheumatologist a review. — Pharma-therapeutica, 1976, 1, 24.
Jaffe I. A, The treatment of rheumatoid arthritis and necrotizing vasculitis with penicillamine. — Arth. Rheum., 1970, 13, 436.
Lyle W. H. Penicillamine; ia Huskisson (Ed.) Clinics in Rheumatic Diseases Vol. 5: Anti-Rheumatic Drugs, p. 569. Saunders, London, 1979.
Lyle W. H., Kleiman R. L. (Eds.) Penicillamine at 21: Its place in therapeutic now. Proceedings of the Royal Society of Medicine, 1977, 70, (Suppl. 3).
Multicentre Trial Group. Controlled trial of D-penicillamine in severe rheumatoid arthritis. — Lancet, 1973, 1, 275.
Азатиоприн
Currey H. L. F., Harris J., Mason R. M. et al. Comparison of azathioprine, cyclo-phosphamide, and gold in treatment of rheumatoid arthritis. — Brit. med. J., 1974, 3, 763.
Urowitz M. В., Gordon D. A., Broder I. Studies into the occurence of soluble antigen-antibody complexes in disease V. Second assessment of correlation between the rheumatoid biologically active factor (RBAF) and the clinical features of rheumatoid arthritis. — Arthr. Rheumat., 1973, 16, 225.
Хлорохин и еидроксихлорохин
Arden G. В., Kolb Н. Antimalarial therapy and early retinal changes in patients with rheumatoid arthritis. — Brit. med. J., 1966, 1, 270.
Hart C. W., Naunton R. F. The ototoxicity of chloroquine phosphate. — Arch. Otolaryng., 1964, 80, 407.
Laaksonen A. L., Koskiahde V., Juka K. Dosage of antimalarial drugs for children with juvenile rheumatoid arthritis and systemic lupus erythematosus. A clinical study with determination of serum concentrations of chloroquine and hydroxychloroquine. — Scand. J. Rheumatol., 1974, 3, 103.
Popert A. J., Meiers K. A. E., Sharp J., Bier F. Chloroquine diphosphate in rheumatoid arthritis. — Ann. Rheumatic Diseases, 1961, 20, 18.
Циклофосфамид
Currey H. L. F., Harris J., Mason R. M. et al. Comparison of azathioprine, cyc-lophosphamide, and gold in treatment of rheumatoid arthritis. — Brit, med. J., 1974, 3, 763.
Cooperating Clinics Committee of the American Rheumatism Association: A controlled trial of cyclophosphamide in rheumatoid arthritis — New Engl. J. Med., 1970, 283, 883.
Pearson С. М., Levy J. Immunosuppressive drugs: Mechanism of action, toxicity and clinical effects. — Clin, in Rheumatic Diseases, 1975, 1, 459.
Хлорамбуцил
Snaith M. L., Holt J. M., Oliver D. O. et al. Treatment of patients with systemic lupus erythematosusincluding nephritis with chlorambucil. — Srit. med. J., 1973, 2, 197.
Метотрексат
Metzger A. L., Bohan A., Goldberg L. S. et al. Polymyositis and dermatomyosi-tis: Combined methotrexate and corticosteroid therapy. — Ann. intern. Med., 1974, 81, 182.
Weinstein G. D., Frost P. Methotrexate for psoriasis. A new therapeutic schedule. — Arch. Dermat., 1971, 103, 33.
Левамизол
Adams J. G. Pharmacokinetics of levamisole. — J. Rheumatol., 1978, 5 (Suppl. 4), 137.
Di Perri Т., Anteri A., Laghi Pasini F., Mattioli F. A weekly oral dose of levamisole in the treatment of rheumatoid arthritis associated with E-roset-te lymphocyte reduction. — Europ. J. Rheumatol. Inflammation, 1978, 1, 155.
Goldstein G. Mode of action of levamisole. — J. Rheumatol., 1978, 5 (Suppl. 4), 143.
Huskisson E. C, Adams J. G. An overview of the current status of levamisole in the treatment of rheumatic diseases. — Drugs, 1980, 20, 100.
Huskisson E. C, Dieppe P. A., Scott J. et al. Immunostimulant therapy with levamisole for rheumatoid arthritis. — Lancet, 1976, 1, 151.
Mielants H., Veys E. M. A study of the haematological side effects of levamisole in rheumatoid arthritis with recommendations. — J. Rheumatol., 1978, 5 (Suppl. 4), 77.
Multicentre Study Group: Levamisole in rheumatoid arthritis. A randomised double-blind study comparing two dosage regimens of levamisole with placebo. — Lancet, 1978a, 2, 1007.
Multicentre Group Study: A multicentre double-blind study comparing two dosage of levamisole in rheumatoid arthritis. — J. Rheumatol., 1978b, 5 (Suppl. 4), 5.
Pinals R. S, The non-haematotogical side effects of levamisole in the treatment of rheumatoid arthritis — a review. — J. Rheumatol., 1978, 5 (Suppl. 4), 71.
Renoux G. The general immunopharmacology of levamisole. — Drugs, 1980, 20, 89.
Ауранофин
Finkelstein A. E., Roisman F. R., Batista V. et al. Oral chrysotherapy in rheumatoid arthritis. — J. Rheumatol., 1980, 7, 160.
W-atz D. Т., Di Martino M. J., Chakrin L. W. et al. Anti-arthritis properties and unique pharmacologic profile of a potential chrysotherapeutic agent: SK&F D-39162. — J. Pharmacol, exp. Ther., 1976, 197, 142.
Weisman M. H., Hannifin D M. Management of rheumatoid arthritis with oral gold. — Arthr. and Rheum., 1979, 22, 922.
5-Тиопиридоксин и пиритинол
Camus J. P., Jaffe I. A., Crouzet J. et al. La pyrithioxine, nouveau traitement de fond de la polyarthrite rhumatoide. Annales de medicine Interne (Paris), 1977.
Huskisson E. C., Jaffe I. A., Scott Jane, Dieppe P. A. 5-Thiopyridoxine in rheumatoid arthritis: clinical and experimental studies. — Arthr. and Rheum., 1980, 23, 106.
Дапсон и сульфасалазин
McConkey В., Davies P., Crockson R. A. et al. Dapsone in rheumatoid arthritis. — Rheumatology and Rehabilitation, 1976, 15, 230.
McConkey В., Amos R. S., Durham S. et al. Sulphasalazine in rheumatoid arthritis. — Brit. Med. J., 1980, 1, 442.
«Лечение ревматических заболеваний»,
под ред. Ф.Д.Харта
Читайте далее:
